Mizuho Securities USA’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Mizuho Securities USA’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$171K	Sell	16,169 -8,831	-35%	-$94K	﹤0.01%	676
2026 Q1	$264K	Hold	25,000	–	–	0.01%	665
2025 Q4	$260K	Sell	25,000 -45,000	-64%	-$476K	﹤0.01%	677
2025 Q3	$723K	Sell	70,000 -89,991	-56%	-$940K	0.01%	629
2025 Q2	$1.66M	Sell	159,991 -40,009	-20%	-$415K	0.04%	440
2025 Q1	$2.02M	Buy	+200,000	New	+$2.01M	0.04%	388

Other funds holding OACC

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Mizuho Securities USA's OACC Position: Q2 2026 in Review

Mizuho Securities USA reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 35% in Q2 2026, selling an estimated $94K and leaving 16,169 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Mizuho Securities USA first reported a position in OACC in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.02M in Q1 2025. 2 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

Mizuho Securities USA held 16,169 shares of Oaktree Acquisition Corp III Life Sciences worth $171K as of Q2 2026.
Mizuho Securities USA sold 8,831 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $94K.
Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Mizuho Securities USA's portfolio in Q2 2026, its #676 holding.
Mizuho Securities USA first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 6 quarters since.
Mizuho Securities USA's Oaktree Acquisition Corp III Life Sciences position peaked at $2.02M in Q1 2025.
2 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.